Karyopharm (KPTI) Sell-Off Overdone, Leerink Partners Says
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall Street ends higher after Democrats win Congress; data center stocks tumble
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
| KARYOPHARM THERAP (NASDAQ: KPTI) | Delayed: 0.07 -0.02 (22.22%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.09 | 52 Week High | $19.41 | |||
| Open | $0.08 | 52 Week Low | $4.83 | |||
| Day High | $0.13 | P/E | N/A | |||
| Day Low | $0.07 | EPS | $-2.74 | |||
| Volume | 40,840,587 | |||||
